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“No society can legitimately call itself civilised if a sick person is 
denied medical aid because of lack of means.”  
Aneurin Bevan, founder of the NHS 
 
Introduction 
Quality public health services protect the most vulnerable in society. They reduce income 
inequality, act as an equalising force and enable people to access healthcare when they 
need it, not when they can afford it. Publically funded healthcare is more efficient, effective 
and more equitable than privately funded systems. However, despite its benefits, publically 
funded healthcare has been under an intensive attack for the last 30 years, as private 
healthcare providers, lobbyists and international finance institutions have demanded the 
commercialisation of healthcare. 
The UK‟s National Health Service (NHS) has been a victim of creeping privatisation in recent 
years, driven by a flawed ideology that competition drives up standards and market forces 
improve efficiency. In reality Public Private Partnerships (PPPs) have driven up costs, and 
more recently clinical commissioning has enabled companies to cherry-pick services based 
on high profits and low costs. Despite these challenges, the NHS is still recognised as one of 
the best health services in the world. This paper shows how the UK government and 
particularly DFID, instead of supporting quality public health services in the global south, are 
using the credibility of the NHS to aggressively promote their ideology of healthcare 
privatisation to poorer countries. 
Since 2010 the international development debate in the UK has primarily focused on the 
campaign to get the British government to invest 0.7 per cent of Gross National Income 
(GNI) in Overseas Development Assistance (ODA). This was successful in 2013, and the 
target was enshrined in law in 2015. It was a commendable achievement, but as this paper 
evidences, whilst attention focused on the size of the aid/development budget and defending 
the concept of aid, DFID‟s priorities changed, including a far stronger emphasis on economic 
growth.  
The UK‟s 2015 aid strategy “Tackling global challenges in the national interest” provides a 
clear sense of the government‟s vision for the private sector in development: 
“Its priorities will include improving the business climate, competitiveness and operation of 
markets, energy and financial sector reform…”  
Far from being a radical solution to poverty alleviation, the privatisation agenda has been 
tried and tested on developing countries for the last 30 years. This has had devastating 
consequences for the millions of people plunged deeper into poverty, but the rewards have 
been significant for multinational companies.  
DFID‟s health policy also shows the level of its support for private health services. It 
emphasises the role of government not as a provider of health services, but as a regulator 
and a provider of finance to non state providers.  
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DFID is increasingly relying on multilateral agencies to implement its pro privatisation 
strategies, including the World Bank, Regional Development Banks and the International 
Finance Corporation (IFC). The IFC has invested heavily in private hospitals in a number of 
countries, and IFC loans have supported the expansion of several global healthcare 
multinational companies. 
Despite their toxic reputation and extortionate cost, DFID and other government departments 
are actively promoting UK expertise in developing public private partnerships in healthcare to 
poorer countries. Healthcare UK is one example, established in 2013 to promote UK 
healthcare providers to “do business overseas”.   
Multi agency projects like HANSHEP are also changing the way public healthcare systems 
operate. Through HANSHEP, DFID was able to fund the establishment of a Public Private 
Partnership advisory facility managed by the IFC, supporting healthcare services for the 
poor.  
This paper details how much of DFID‟s work is now delivered by private providers and 
consultants, many of which specialise in the privatisation of public services, public private 
partnerships and public management reforms.  
The CDC group, the UK government‟s bilateral development finance institution has invested 
heavily in a range of private health initiatives, particularly private fee paying hospitals, 
targeting middle and high income groups.  
DFID is increasingly using the UK‟s development/aid budget to promote the commodification 
of healthcare. Rather than contributing to the eradication of poverty, it is resulting in the 
channeling of scarce public resources in poorer countries to the private sector, including 
multinational health companies.  
This paper highlights the scale and scope of this strategy, and some of the damage it is 
already doing. It also makes the case for the alternative; quality public health services which 
have been proven to be the fairest, most efficient and effective way to meet the health needs 
of the whole population.  
UNISON calls on DFID to reassess its health strategy and end its support for initiatives that 
promote the privatisation of healthcare. Instead it should focus on the eradication of poverty, 
through support for quality public healthcare systems. 
Dave Prentis, General Secretary, UNISON 
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What is healthcare privatisation – transforming public healthcare 
systems? 
 
Public funding 
 
Public funding for public health services, paid from general taxation, provided free at the 
point of access, is considered the most effective in redistributing resources from high to low 
income groups, if measured by the improvements in health and impact on economic growth.   
Many national healthcare systems have been established through public funding.  The 
underlying principle is that a system of universal healthcare provision funded through 
taxation allows the risks to be shared across the population.  Some people use health 
services more at certain times in their lives than at others.  People from high income groups 
generally live longer in better health than those from low income groups, who have a shorter 
life expectancy and higher levels of morbidity.  Other individuals have certain conditions 
which need a high level of health treatment.   
 
The allocation of funds reflects some of the factors that influence demand for healthcare and 
are part of a process of allocating risk, for example, regions with a high proportion of older 
people or high levels of unemployment and socio-economic disadvantage.  Governments 
have developed different methods of calculating how much healthcare to fund, with many 
governments introducing new payment systems over the last 20 years.  These have 
changed from redistributive systems to more market-based pricing systems within healthcare 
systems, which pay for treatment per person according to a specific type of diagnosis 
(diagnostic related groups).  Although the principle of a tax based healthcare system is that it 
is free at the point of access, some governments have made care more restricted or subject 
to user fees. 
 
The disadvantage of tax based healthcare is that it may be subject to changes in 
government spending priorities.  Austerity policies have affected healthcare spending.  
Hypothecated taxes on specific products, for example, tobacco, alcohol, can also be used to 
fund public healthcare, which will not be influenced as much by changes in government 
spending priorities. 
 
Publicly funded healthcare is more efficient, effective and more equitable than privately 
funded systems. They enable people to access healthcare when they need it rather than 
when they can afford it.   Publicly funded health services contribute to redistribution of 
income more than privately funded services. 
 
Privatisation of health services takes many forms.  It is an implicit element of health sector 
reform, which is underpinned by fiscal reform. New systems of fiscal control, new ways of 
allocating resources in line with overall government goals and pressure to improve the use of 
resources are three dimensions of fiscal reform that have implications for the health sector.1 
Allocation of resources in line with government goals has meant that the interests of the 
finance and treasury ministries are dominant. This may affect the health sector directly 
because the goals of the finance ministry will often not be those of the health ministry.  2 It 
also leads to a greater emphasis on performance management.  3 Outputs and outcomes 
are not always easy to define in the health sector and can lead to a distortion of healthcare 
delivery e.g. increases in “throughput”, which focus on the numbers of patients treated rather 
than the quality of care. 
 
New systems of fiscal control are often accompanied by the introduction of market 
mechanisms, which affect the health sector in several ways:  business principles and 
practices are introduced to healthcare institutions, often as part of wider organisational 
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restructuring. This process is known as corporatisation and is taking place in both 
developing and developed countries. 4  It is almost always accompanied by the introduction 
of the purchaser-provider split within a national healthcare system to create an internal 
market. The outsourcing and contracting out of services, for example, catering, cleaning, 
facilities management, hospital management and clinical services, is part of an overall 
process of privatisation.  Drug manufacturing and drug distribution may also be privatised.  
Together these processes constitute a process of marketisation. 
 
The processes that result in healthcare privatisation cover what can be seen as a continuum 
of commercialisation.  These start from the introduction of internal markets to public health 
systems, corporatisation of public hospitals, contracting out of services, public–private 
partnerships and ultimately the privatisation of healthcare services.   
 
Table 1: Typology of privatisation and marketisation for the health sector 
 
Process Examples 
Marketisation and 
privatisation of 
assets and 
services 
 Commissioning of public services from private & voluntary 
sector – diverse or mixed providers 
 Marketisation and expansion of private services 
 Private financing of infrastructure and services with public-
private partnerships/ private finance initiative 
 Choice and personalisation of services 
 Deregulation/ liberalisation and reregulation 
 Commercialisation of public services 
 Sale of assets to private sector 
 Sale and lease back of government buildings 
 Increased household responsibility for payments and care – 
informal payments, user fees 
Privatisation of 
governance and 
democracy 
 Contract governance 
 Corporatisation of quasi-public bodies, e.g. hospitals 
 Private companies established within public services 
 Privatisation of public interest information and resulting 
reduction of transparency and disclosure 
Privatisation of 
public domain 
 Public service values replaced by market ideology and 
commercial values 
 Privatisation of public intellectual capital 
Source: Adapted from Whitfield, 2006 5 
 
This table shows some of the different categories of public and private arrangements for 
healthcare provision.  These will not necessarily apply to all countries but will be shaped by 
the existing arrangements for healthcare provision.  For example, some countries have an 
existing charitable/ non-governmental organisation healthcare sector.   The healthcare 
systems of Africa and Asia have different histories with differing influences of the not-for-
profit and private sector.  Part of health sector reform involved the decentralisation of 
budgets to district hospitals, the introduction of self-management for hospitals and the 
introduction of business models and private sector forms of management.  The introduction 
of the purchaser-provider split and informal payments, user fees and co-payments were also 
introduced as part of health sector reform. 
 
Since the late 2000s, there has been a noticeable change in the way in which healthcare 
privatisation has been promoted.  This paper will show that this can be characterised by 
three processes: 
 Development of larger health providers from small/ medium sized private healthcare 
providers; Establishment of new healthcare enterprises; 
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 Promoting health insurance for low income groups; 
 Creating consumer awareness of market opportunities for buying healthcare. 
 
Poverty reduction and economic growth  
 
The UK government has consistently argued that it is one of the few national governments 
which are committed to maintaining its aid/development budget at 0.7% of Gross Domestic 
Product (GDP) during a period of austerity, when the budgets of other government 
departments are being cut.  In 2013, the UK became the only G20 country to achieve the UN 
target of spending 0.7% of Gross National Income as Official Development Assistance 
(ODA). 6   
 
In order to understand how the aid/development budget is used, a wider analysis of DFID 
policies in relation to poverty reduction and economic growth is set out below.   Economic 
development has become a priority for DFID, which is part of a process of working together 
across several government departments to promote economic development in new markets.  
In 2015/16, DFID plans to spend £1.8 billion of the bilateral budget on economic 
development. 7  In 2014-15, the DFID bi-lateral aid budget was £4.3 billion so that assuming 
the bi-lateral aid budget remains about the same size, about 40% of it will be spent on 
economic development.   
 
The private sector is seen as playing a crucial role in reducing poverty and this justifies 
DFID‟s increasing involvement with the private sector at international, national and local 
levels.  This is affecting the way in which DFID works and the skills that DFID staff are 
expected to develop.  In 2014-15, DFID reported that all senior DFID civil servants are 
required to complete Commercial Awareness Training and 200 Senior Responsible Officers 
in DFID have also received training.  Commercial advisers are being appointed to strategic 
DFID departments to “provide commercial expertise on the ground.” 8 
 
This focus on commercial skills is also taking place in the Foreign and Commonwealth Office 
(FCO) and other government departments.    In 2011, „Guidance for DFID, UKTI and FCO 
staff on HMG‟s Commercial Diplomacy and Untied Aid Agenda‟ was published which set out 
the UK government‟s strategy for working with business for development. The Conservative-
led Coalition government had stated that “promoting UK commercial interests will be central 
to its foreign policy.” 9  
 
However the position of DFID is different to that of other governments because the 
International Development Act (2002) does not allow DFID to use staff time or resources to 
promote UK commercial interests.  The 2011 Guidance does state that “if development 
assistance that is provided by DFID satisfied the tests in the IDA, it is legitimate for DFID to 
support spin-off commercial benefits to the UK resulting from that assistance, provided they 
are not its primary purpose”.  10  The Guidance makes recommendations about how UK 
Trade & Investment (UKTI)  and Foreign & Commonwealth Office (FCO) staff should “ensure 
DFID colleagues and beneficiary government and aid agency in-country representatives are 
aware of how the expertise of the UK commercial sector could contribute to the delivery of a 
particular country‟s development strategy.”  11   
 
These policies are continuing under the new Conservative government, as seen in the 
recently published „UK aid: tackling global challenges in the national interest‟ (2015) 
strategy, which is published by the UK Treasury and DFID. 12  This strategy aims to cover 
strengthening of global peace, security and governance, resilience and response to crisis as 
well as promoting global prosperity and tackling extreme poverty and helping the most 
8 
vulnerable.  The promotion of global prosperity will be implemented through a new cross-
Government Prosperity Fund, led by the National Security Council.   
 
“Its priorities will include improving the business climate, competitiveness and 
operation of markets, energy and financial sector reform, and increasing the ability of 
governments to tackle corruption. These reforms will contribute to a reduction in 
poverty in developing countries, and will also create opportunities for international 
business, including UK companies” (p.17 UK Aid 3.15 Promoting Global prosperity).   
 
„UK aid: tackling global challenges in the national interest‟ does not mention the protection or 
strengthening of public services or even make any reference to public services.   There is a 
fine line between the core work of DFID and the promotion of commercial interests.  This 
report will go on to examine how this process works in practice in relation to healthcare 
privatisation. 
DFID health policies 
 
DFID published a „Health Position Paper Delivering Health Results‟ in 2013.  An analysis 
shows how DFID is approaching health policy as well as the role of the private sector in its 
delivery.  The position paper sets out some of the underlying assumptions and philosophies 
that DFID has in relation to the role of public and private providers.  Health systems are 
always defined as consisting of public and private providers. 
 
“It aims to maximise health gains through targeted, cost-effective health interventions 
that are delivered through strengthened, more efficient and effective health systems 
(including both public and private providers) and that engage communities in the 
promotion and protection of their own health.”  13 
 
Although DFID‟s overall approach is to support the long term development of the health 
system, sometimes it will support the private sector: 
 
“In some circumstances this means supporting private sector providers (for-profit or 
non-profit, formal or informal) to deliver more good quality essential health 
commodities and services to poor people, and helping to strengthen the capacity of 
governments to regulate these providers and to finance use of the services by the 
poor. For example, the African Health Markets for Equity programme is supporting 
the provision of cost-effective essential health services by franchised private 
providers in Kenya, Ghana and Nigeria, as well as supporting governments to build 
their capacity for engaging with and regulating the private sector, and introducing 
demand-side financing mechanisms to ensure that poor people can benefit from the 
services.” P.10 
 
DFID identifies the role of government as that of financing health services and regulating 
diverse providers.  It emphasizes that some people will be too poor to make a contribution to 
the cost of healthcare and so government will have to cover their costs. 14  Although 
admitting that privately provided services can be of variable quality, DFID still maintains that: 
 
“private providers can be much more sensitive to demand and sometimes offer better 
value for money than public providers. There are therefore great potential benefits 
from improving their incentives to deliver better quality services more equitably. 
Developing governments‟ capacity to contract, regulate, supervise and monitor 
private provision of services so that non-state providers become an integral part of 
scaling up cost-effective coverage of quality health services for the poorest is a very 
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challenging but an increasingly pressing need if all people are to be reached with 
services at reasonable cost.”  15 
 
DFID‟s health policy shows that it supports the promotion of private health services.  The 
role of government is seen as one of regulation and the provision of finance for health 
services but not being a provider of health services. 
 
The size of the DFID bi-lateral aid budget for the health sector has increased since 2009 
from £696,996,000 (14.5% of total bi-lateral aid) to £1,297,140 (19.20%) in 2013.  The 
structure of this budget has changed during this period with the „basic health‟ expenditure 
increasing from £252,717,000 to £757,105,000 in 2013.  In the DFID Annual Report 2014-
15, it reported that “DFID supports the provision of good-quality health services for all. DFID 
also supported 30 countries to strengthen their systems for financing health and deciding 
how to allocate resources.” 16 This can be interpreted as support for health systems reform.   
 
Table 2: DFID Bi-lateral aid – health sector 2009-2014 and as % of overall bi-lateral aid 
 
Health 2009 % 2010 % 2011  2012 % 2013 % 
 696,996 14.50 780,957 15.00 946,230 18.0 1,076,713 19.40 1.297,140 19.20 
Health, 
general 
140.676 2.90 178,88 3.40 127,908 2.40 177,710 3.20 209,453 3.10 
Basic 
health 
252,717 5.30 269,250 5.20 422,816 8.00 473,501 8.50 757,105 11.20 
Population 
policies 
303,602 6.30 332,819 6.40 395,506 7.50 425,501 7.70 330,581 4.90 
 
Source: Data.gov.uk/dataset/statistics/statistics-on-international-development-2014/ 
International policy context  
 
DFID operates within global/ international policies.  One example is the concept of Universal 
Health Coverage (UHC), which has been promoted by the World Health Organisation (WHO) 
and the World Bank as a way of giving people access to adequate healthcare.  It is 
significant that the „problem‟ is seen as a financial one rather than one of delivery of care, 
free at the point of use.  Universal Health Coverage requires a health financing system, 
which pools funds to provide services to the population, often as a basic package of 
healthcare services.17  In this sense, it separates the financing from the provision of services 
and facilitates the entry of private insurance companies and private providers into national 
strategies of universal health coverage.  Governments may only partially be involved.   It 
complements many of the changes that have been introduced through health sector reforms, 
which have increased the role of the private sector in healthcare provision.   
 
Increasingly, DFID is relying on multi-lateral agencies, such as the World Bank Group, 
Regional Development Banks and alliances of international agencies, to implement part of 
DFID strategies.  The DFID multilateral budget has increased since 2010.  The way in which 
DFID uses multilateral agencies to implement many of its policies means that DFID funds 
are closely tied to the implementation of World Bank/ IFC policies such as „Markets for Poor 
people‟ and the IFC strategy to promote small healthcare providers.   
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Table 3: Contributions to multi-lateral agencies 2013-2014 of over £200,000 (£ thousands) 
 
 2013 2014 
African Development Fund 200,951 208,033 
Clean Technology Fund 229,000 111,692 
EC Development Share of 
Budget 2 
812,615 816,311 
EC European Development 
Fund 
406,876 327,528 
Global Alliance for Vaccines 
and Immunization GAVI 
323,330 269,446 
Global Fund to Fight AIDS, 
Tuberculosis and Malaria 
542,525 285,000 
International Bank for 
Reconstruction and 
Development (part of World 
Bank Group) 
716,547 602,442 
International Development 
Association (IDA) –part of 
World Bank Group 
1,112,000 1,641,180 
UNICEF 324,069 323,132 
UNDP 269,701 234,720 
World Food Programme 282,805 245,068 
Source: DFID Table A11 UK ODA by Multilateral Agencies 2013-14 
 
The largest contribution is to the International Development Agency (IDA) which is part of the 
World Bank Group.  This has increased from £1,112,000,000 to £1,641,180,000 in 2014.  
The International Bank for Reconstruction and Development, also a part of the World Bank 
Group was £716,547,000 in 2013 but dropped to £602,442,000.   Another large contribution 
is to the EC Development Share of Budget 2 and the EC European Development Fund.  
Contributions to the Global Alliance for Vaccines and Immunization (GAVI) and to the Global 
Fund to fight AIDS, Tuberculosis and Malaria have both dropped since 2013. 
 
DFID‟s increased multi-lateral agency expenditure has been subject to criticism by 
Parliament.     The contributions to multi-lateral agencies are expected to fall from 42% of the 
DFID budget to about 38%.  18    The International Development Committee, in its 
investigations of DFID expenditure/ operations at country level and through specific projects, 
has been critical of the lack of control that DFID has of its multilateral spending.  (This will be 
discussed in the Liberia case study). 
 
World Bank and Regional Development Banks 
 
The World Bank has been promoting health sector reform for over two decades by 
implementing decentralisation, public-private partnerships and the legislative and managerial 
changes required to implement these policies.  It works with other multi-lateral agencies and 
national development agencies, for example, DFID, to promote these agendas.  Many recent 
World Bank projects show that „payment by results‟ or „performance based financing‟ are 
being introduced to make health services more efficient.  Funding is made available using 
these mechanisms, so that health facilities will only be given funding if they provide services 
which have an impact on health status.  The underlying assumption is that health workers 
need incentives if they are to deliver services efficiently and effectively.  A recently approved 
project on improving maternal and child health services for the Democratic Republic of 
Congo (DCR) is using „results based financing‟ which pays for outcomes and results rather 
than inputs.  Income from performance based financing is used by health facilities and health 
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administration to buy inputs and performance bonuses.  This introduces a competitive 
element into the healthcare system.   Performance based financing is an integral part of 
World Bank projects in Chad, Cameroon, Moldova, Zambia, Ethiopia, Nigeria.  DFID also 
uses „payment by results‟ to implement its funding.   
 
Some of the same themes that are evident in World Bank projects also emerge in health 
projects funded by the Asian Development Bank.  „Results based lending‟ is a form of 
„payment by results‟ and is part of technical support for the India National Urban Health 
Mission.  Public-private partnerships (PPPs) are also part of ADB funding projects.  A project 
in Thailand is explicitly aiming to improve the capacity of the Public Health Ministry to 
„identify, develop and implement PPP projects and to draw more private sector funding into 
the health sector‟.  In Mongolia, a project is aiming to improve the social insurance system 
through institutional strengthening. 
 
The emphasis of Africa Development Bank health projects is more on ways of addressing 
communicable diseases, e.g. HIV/AIDS and tropical diseases, and providing basic health 
services. 19   The underlying approach to the provision of basic health services is through the 
provision of a „safety net‟.  For example, the Africa Development Bank has funded a project 
in Morocco which supports the „universal coverage of the social safety net‟. It will focus on 
the management and financing of the reforms, the extension of medical coverage and the 
regulation and provision of care.  It is also investing in a network of high quality tertiary care 
and education centres in East Africa, which will stimulate social economic development.  
Upgrading and improving nursing and other forms of health worker training is another priority 
of Africa Development Bank health projects, for example, Egypt, which will be delivered 
through a public-private partnership.  20  In 2015, the African Development Bank made an 
investment of US$ 25 million in the Abraaj Growth Markets Health (Africa) Fund, part of the 
Abraaj Growth Markets Health Fund, a private equity fund. 21  This loan will provide finance 
for “scalable and sustainable healthcare models for lower-middle and low-income segments 
of the populations in Africa”. 22   
 
International Finance Corporation (IFC)  
 
The International Finance Corporation is part of the World Bank Group with a specific remit 
to promote the private sector in low and medium income countries.  It plays a significant role 
in the promotion of private healthcare.  Its recent healthcare investments are set out in Table 
4. 
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Table 4:  IFC healthcare investments 2012-2016      
 
Date Project Company Country IFC 
investment 
for loan 
US$m 
IFC 
investment 
for equity 
Total IFC 
loan 
approved 
09/04/2012 MNT Saglik 
Hizmetleri Ve 
Ticaret As 
MNT Saglik 
Hizmetleri Ve Ticaret 
As 
Turkey 15 15 30 
22/05/2012 IHH Healthcare 
Berhad 
IHH Healthcare 
Berhad 
East Asia  47.29 47.29 
20/10/2012 Concord Medical  Concord Medical 
Services Holdings 
Ltd 
China 50  50 
30/04/2013 Chad Clinic Clinique La 
Provence 
Chad 1.38 
 
 1.39 
08/05/2013 Fortis Healthcare Fortis Healthcare East Asia 55 
 
45 100 
14/05/2013 AAR Healthcare  AAR Healthcare  East Africa  
 
4 4 
30/05/2013 STS Holdings Ltd STS Holdings Bangladesh 17.5 
 
11 28.5 
13/11 2013 Intermed Intermed Medical 
Centre LLC 
Mongolia 10  10 
30/01/2014 Sala Uno Sala Uno Mexico  
 
2.24 2.24 
17/02/2014 IFHA II IFHA II Cooperatief Africa  
 
24 24 
04/03/2014 Nephro Plus Nephro Plus Health 
Services Private Ltd 
India  7 7 
29/04/2014 Metropolitano Hospital 
Metropolitano SA 
Nicaragua 4.35  4.35 
24/06/2014 Adana Health ADN PPP Saglik 
Yatirum AS 
Turkey 46.16  48.66 
includes  
13 
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US$3m risk  
07/07/2014 Centro Hospitalario 
Serena Del Mar 
Centro Hospitalario 
Serena Del Mar 
Colombia 20  20 
11/07/2014 Kayseri Health ATM Saglik Kayseri 
Yatirim AS 
Turkey 43.66 
 
 45.66 (incl. 
+2 risk 
investment) 
10/09/2014 Rede Dor II Rede D‟Or Sao Luiz 
SA 
Brazil 50 
 
 50 
06/10/2014 Asia Heart Wuhan  Asia Heart Hospital China 35 
 
 35 
31/10/2014 Etlik Health Ankara Etlik Hastane 
Saglik Hizmetleri 
Isletme Yatirim AS 
Turkey 85.02 
 
 88.02 (incl 
3m risk 
invesmtset 
03/11/2014 ESIP EyeQ Eye-Q Vision Pvt Ltd India  
 
5.36 5.36 
10/04/2015 Ciel Healthcare Ciel Healthcare Ltd Africa  
 
6.75 6.75 
0/05/2015 Conclina Conjunto Clinico 
Nacion CA 
Ecuador 15  15 
28/07/2015 Iso Health Ltd Iso Healthcare Ltd Kenya 4.41 1.31 5.73 
14/09/2015 Hygeia 2014 Hygeia Nigeria Ltd Nigeria  
 
12.4 12.4 
16/09/2015 Falck Africa SPV  Falck A/S Africa  
 
20 20 
14/10/2015 UFH Guangzhou 
Loan 
UFH Guangzhou 
United Family 
Hospital   
China 60 
 
60 
13/11/2015 Columbia China China Rehabilitation 
hospital Private 
Hospital 
China 25 25 50 
16/03/2016 HCG Healthcare Global 
Enterprises Ltd 
India  19.9 19.9 
Source: IFC
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Hospitals have remained the main focus of IFC healthcare investments over the last decade.   
India has received six investments and China and Turkey five each.  These reflect the 
emphasis on the development of a corporate healthcare sector in all three countries.  Kenya 
has received three investments and Colombia two, which again reflect the emphasis on the 
development of a private healthcare sector, perhaps on a smaller scale.  Three of the 
Turkish investments needed risk guarantee loans taken out by IFC.  These are the only IFC 
hospital investments which have required this, an indication of Turkey‟s political instability. 
 
Table 5: Number of IFC healthcare investments by country 
 
Country  Number of 
investments 
India 6 
China 5 
Turkey 5 
Kenya 3 
Colombia 2 
Chad 1 
East Asia 1 
Bangladesh 1 
Mongolia 1 
Mexico 1 
Nicaragua 1 
Brazil 1 
Africa 1 
Nigeria 1 
Romania 1 
Georgia 1 
 
Another important feature of IFC investments over the last decade is that several companies 
have started to emerge as global healthcare multinational companies. IHH Healthcare 
Berhad and Fortis Healthcare have expanded throughout Asia. 23 AAR Healthcare has 
expanded in Africa. 24 Falck A/S is a Danish company which has expanded with emergency 
health services throughout Europe and is now moving into Africa and other parts of the 
world. 25 This shows how IFC loans can provide a springboard for the expansion of 
multinational healthcare companies. 
 
Although the overall aim of IFC investments is to support private sector development in 
several sectors, its healthcare investments remain concentrated in larger hospital projects.   
Several investments are public-private partnerships.    An analysis of IFC healthcare policy 
over the past decades shows that initially there were plans to expand health insurance 
companies as well as healthcare providers but this has not led to an expansion of health 
insurance.  This has some implications for existing healthcare investments in that private 
healthcare providers are dependent on private patients being able to pay.   
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DFID makes its largest multi-lateral agency contribution to the International Development 
Association which is part of the World Bank Group.   IFC healthcare investments fit into 
DFID‟s overall plan for promoting private healthcare but particularly through growing 
companies which can expand globally.  
 
Multi-lateral Investment Guarantee Agency (MIGA) 
 
The Multi-lateral Investment Guarantee Agency (MIGA) is also part of the World Bank Group 
and has a remit to promote foreign direct investment and loan guarantees to private sector 
investors.  Although most of its investment are in infrastructure, for example, waste water, 
roads, in 2015 it invested in a Turkish hospital project.   This was to build a 475-bed hospital 
in Yozgat as part of the Turkish Health Public-Private Partnership Program (PPP) to 
renovate public hospital infrastructure.  26  A loan of $51.7 million has been made to 
Meridiam Eastern Europe SARL of Luxembourg and Siemens Financial Services covering 
their investments in YZG Sağlık Yatırım A.Ş. in Turkey. The coverage is for a period of up to 
20 years and 18 years respectively and covers the risks of transfer restriction, expropriation, 
and breach of contract.  The contract is for a 27-year design, build, finance, operate, and 
transfer project agreement and it is hoped that it is the first of many more PPP projects. 27 
 
Consultants and private providers 
 
The promotion of healthcare marketisation and privatisation is not just the result of funding 
by DFID, other government departments and multi-lateral agencies.  Consultants and private 
providers of management advice contribute to the dissemination of market based 
approaches to healthcare delivery.  Much of DFID‟s work is delivered by consultants.   The 
top DFID private sector implementers in 2014 were:  
 
Table 6: DFID private sector consultants and implementers (2014) 
 
 Name Activities Amount 
awarded DFID 
funding 
 1 Crown Agents 
Headquarters: London, U.K. 
Awarded DFID funding:  
Works with 
governments on 
issues of health, 
governance, 
humanitarian 
response, economic 
development 
£191.6 million 
 2 Pricewaterhouse Coopers 
Founded: 1998 
Headquarters: London, U.K. 
Chairman: Dennis Nally 
Professional services 
& accountancy 
services 
£122.2 million 
 3 Adam Smith International 
Founded: 1992 
Economic & 
government reform 
£88.4 million 
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Headquarters: London, U.K. 
Managing director: William Morrison 
 4  DAI 
Founded: 1970 
Headquarters: London, U.K. 
President and CEO: James Boomgard  
Social and economic 
development problems 
caused by inefficient 
markets, ineffective 
governance and 
instability 
£58.3 million 
 5  GRM International Future 
Founded: 1965 (as Gunn Rural 
Management) 
Headquarters: Brisbane, Australia 
Managing director: Kim Bredhauer 
Development project 
planning, design and 
management services, 
and feasibility studies. 
£50.5 million  
 6 Mott MacDonald Group 
Founded: 1989 
Headquarters: London, U.K. 
Managing director: Richard Williams 
 
Infrastructure £39.4 million  
(including 
member 
companies such 
as BMB Mott 
MacDonald, 
Cambridge 
Education and 
HLSP) 
 7 Oxford Policy Management 
Headquarters: Oxford, U.K. 
Policy review & 
implementation 
£26.7 million 
 8  
Coffey International Development 
Headquarters: Canberra, Australia 
Wide range of 
development issues – 
government reforms 
£23.7 million  
 9 Abt Associates 
Founded: 1965 
Headquarters: Massachusetts, USA 
Managing director: Kathleen Flanagan 
Health, social and 
environmental policy 
and international 
development 
£21.4 million  
 10 Maxwell Stamp 
Founded: 1959 
Headquarters: London, U.K 
 
Economics 
consultancy 
£19.9 million  
 11 Health Partners International 
Headquarters:  
 £19.4 million 
 12 ECORYS 
 
Headquarters: Rotterdam, The Netherlands 
Economic and social 
development 
£17.7 million 
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 13 
Options Consultancy Services 
Founded: 1992 
Headquarters: London, U.K. 
Managing director: Jo Elms 
Sexual and 
reproductive health, 
maternal & child 
health, HIV/AIDS, 
citizen voice and 
accountability, gender, 
social inclusion, and 
equity to strengthen 
pro-poor health 
systems. 
£15.4 million 
 
 
 
 
 
 14  IMC Worldwide 
Founded: 2011 
Headquarters: Redhill, U.K. 
Managing director: Gavin English 
Previously owned by WSP Group until 2011 
Planning, design and 
management of global 
infrastructure projects 
£14.3 million 
 15 
IPE Global Private Limited 
Headquarters: New Delhi, India 
Founded: 1998 
Managing Director: Dr. Swapan Kanti 
Chaudhuri 
Technical assistance 
and solutions for 
equitable development 
and sustainable 
growth in developing 
countries 
£13.6 million 
 16  
Charles Kendall & Partners 
Founded: 1948 
Headquarters: London  
Global Operations Director: Mark Kendall 
Supply chain 
management  & 
procurement 
consulting 
£11.3 million 
 17 
International Procurement Agency 
Founded: 1981 
Headquarters: Bossum, The Netherlands 
 
Supply services, 
Procurement services, 
Consultancy services 
and Emergency 
Response 
£10.8 million 
 18 KPMG 
Founded: 1987 
Headquarters: Amstelveen, the Netherlands 
Awarded DfID funding: 10.1 million pounds 
Global professional 
services & 
accountancy services 
£10.8 million 
 19 Air Partner 
Founded: 1965 
Headquarters: London 
Managing Director:  
Chartering aircraft £9 million 
 20 
Atos Consulting 
Founded: 1997 
Headquarters: London, U.K.  
IT and outsourcing  £8.5 million  
Source: Devex  28 
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In 2011-12, consultants and private providers accounted for 9% of DFID‟s aid expenditure.   
29  30  Apart from the large sums of money that each consultant/company receives, two of the 
largest global professional and accountancy services companies (PWC and KPMG) are 
included.  Adam Smith International is part of the Adam Smith Institute, a think tank that 
promotes market solutions.  Several companies specialise in economic and government 
reforms.  Another group of companies promote privatisation of public services, public-private 
partnerships and public management reforms.  All these companies have expertise to 
promote public sector reforms and the privatisation of health services. 
 
The range of projects that these private sector consultancies are involved in show how their 
expertise is used to „strengthen health systems‟.  The Crown Agents have implemented two 
health projects recently: results based financing in Zimbabwe, commissioned by UNICEF 
and; improving public health supply chains – lessons from the private sector, Zambia.  
Options are responsible for implementation of many UKAID funded projects, which include 
„Strengthening Urban Health Systems in Bangladesh‟ and one element of the project is 
promoting the use of voucher schemes “so urban poor can access health services that 
would otherwise pay for”. 31  In Kenya, Options is delivering a programme on Maternal and 
Newborn Improvement Project which includes performance based financing for clinics.  
Options is also working with the Crown Agents and Oxford Policy Management to deliver 
health systems strengthening in Nepal.32     
 
Mott MacDonald has worked on health projects in Nigeria, Bangladesh and Turkey.  In 
Turkey, Mott MacDonald is as an adviser to lenders for four integrated health complexes 
delivered through public-private partnerships at Kayseri, Etlik and Bilkent in Ankara, and 
Ikitelli in Istanbul.  Mott MacDonald will assess design, planning and construction, facilities 
management and lifecycle proposals. Etlik and 3700 bed Bilkent campuses will be among 
the largest in the world.  33 
 
DFID and Development Finance 
 
The implementation of DFID policies for development finance takes place through a range of 
agencies and initiatives.  The most important agency is the CDC Group, the UK bi-lateral 
development finance institution.    
 
The CDC Group 
 
The CDC Group was founded in 1948 as the Commonwealth Development Corporation.  It 
has a long history of investing in development infrastructure projects.  Since 2004, it has 
focused on obtaining a commercial return on its investments.  This is in contrast to other 
national development finance institutions which often invest where commercial returns on 
investment are more difficult. 34  The National Audit Office, in a report for the International 
Development Committee in 2010, commented that although the performance of CDC since 
2004 was higher than expected, and that although it was accepted the economic growth was 
a “precondition for pulling and keeping people out of poverty, the direct effect of specific 
investments on poverty reduction for poor people is harder to demonstrate”. 35   
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Table 7: CDC Investment portfolio proportion for healthcare 
 
Year % on healthcare 
2010-11 10% 
2011-12 6% 
2012-13 3% 
2013-14 4% 
Source: Annual reports 2010-2014 
 
Table 8: CDC healthcare investments  
 
Year Project 
2010 Fund manager Actis invested in healthcare provider Sterling Add-Life, which 
has 770 beds across five multispeciality hospitals in Ahmedabad, Baroda, 
Rajkot, Mundra and Bhavnagar. In 2013, sold by Actis to Girish Patel, 
AddLife Investments.36 
2011 1,100 bed Tertiary and specialty care beds, mostly in underserviced 
geographical regions through three hospital investments in a South Asia 
fund. 
2012 Beams Hospitals is only one of three chains in India offering out-patient 
laparoscopic surgical services. The capital from Ambit Pragma will help the 
company expand from a single physician practice to five centres. 
2013 US$17.5m Equity investment for Rainbow Healthcare, India – a 450-bed 
paediatric and maternity healthcare chain based in the southern Indian state 
of Andhra 
Pradesh.  Investment will be used to build more hospitals.  
2014 Narayana Health is the third largest hospital business in India and is 
becoming India‟s leading low-cost healthcare company.  CDC investment 
will help expand hospitals in Kolkata, Lucknow, Bhubaneshwar and 
Bangalore. 
Source: CDC Annual Reports 2010-14 
CDC does not receive money directly from DFID but raises funds for investments through 
commercial investors and other development finance institutions, for example, national or 
international public agencies investing in the private sectors of emerging economies. 37  The 
percentage of its portfolio invested in healthcare has declined since 2010.  However, in „UK 
Aid: tackling global challenges in the national interest‟ (2015) DFID announced that it would 
be investing £735 million in CDC.  38 
 
An analysis of CDC investments in health services in India shows that the majority of 
investments are in hospitals, with a smaller proportion in drug and pharmaceutical 
companies.  Only one hospital investment, Vaatsalya, aims to provide affordable healthcare 
in smaller towns in Karnataka and Andhra Pradesh, by bringing primary and secondary care 
together.   It has 15 hospitals and is the first hospital network to target smaller towns.39  All 
the other CDC investments are in private, fee paying hospitals as seen from their websites, 
which have systems for electronic payment of fees as well as electronic appointment 
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systems.  These features suggest that they are likely to attract high and middle income 
groups. Several companies are specific about targeting international medical tourists from 
Europe and the United States.    
 
In the case of India, these investments need to be seen in the context of the expansion of 
the private healthcare sector in hospital care in some states in India, for example, Andhra 
Pradesh, Gujarat, Kerala and Maharashtra.  In these states, middle and high income groups 
have moved out of the public sector and poor people rely solely on the public hospital sector. 
40  This has implications for cross-subsidisation of universal healthcare services.  If middle 
and high income groups leave the public services, they will be unwilling to contribute through 
taxation to public healthcare services, leaving public healthcare services underfunded and of 
poor quality.  
 
DFID has also set up several initiatives to involve the private sector in partnership.  These 
cover direct funding arrangements for the private sector as well as the creation of public-
private partnerships.   They are smaller investments which show how DFID‟s healthcare 
funding is not just made available to large hospitals but is also targeted at small and medium 
sized enterprises.  Three initiatives which involve the development of small-scale healthcare 
services are: 
 HANSHEP Harnessing non-state actors for better health for the poor 
 Business Innovation Facility (BIF);41 
 Impact Investment Fund (IIF).42 
 
HANSHEP Harnessing non-state partners for better health for the poor 
 
HANSHEP shows the nature of the healthcare projects that DFID is promoting.  HANSHEP 
is a group of development agencies and countries, established by its members in 2010, 
which aims to „improve the performance of the non-state sector in delivering better 
healthcare to the poor by working together, learning from each other, and sharing this 
learning with others‟.43  The members are: 
• African Development Bank (AfDB) 
• Bill & Melinda Gates Foundation 
• Government of Rwanda (Ministry of Health) 
• Government of Nigeria (Ministry of Health) 
• International Finance Corporation (IFC) 
• KfW Entwicklungsbank (KfW) and Deutsche Gesellschaft für Internationale 
Zusammenarbeit (GIZ) on behalf of the German Federal Ministry for Economic 
Cooperation and Development 
• Public Health Foundation of India (PHFI) 
• Rockefeller Foundation 
• UKaid from the Department for International Development (DFID) 
• United States Agency for International Development (USAID) 
• World Bank. 
This range of members draws together a mix of government departments, charitable/ private 
foundations, the World Bank Group and a regional development bank.  It shows how 
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alliances are being created at international level between governments, foundations and 
international financial agencies.   
 
The range of HANSHEP projects show how DFID funds projects which facilitate changes in 
the way in which public healthcare systems operate.  They cover the creation of health 
markets and market innovations, health enterprises and the development of public-private 
partnerships in different contexts.  For example, in 2012, HANSHEP set up a Pilot Health 
PPP Advisory Facility, which is managed by IFC, to provide advice for governments in 
developing and implementing public-private partnerships supporting healthcare services for 
the poor.  Between 2012 and 2016, the initiative has been collecting evidence on the 
adaptation and implementation of health PPPs in low income countries and disseminated 
this evidence to health and finance policy makers in low income countries.  It aims to provide 
comprehensive technical assistance for senior government officials in low and lower middle 
income countries so that they can evaluate health PPPs. This initiative will also test the 
effectiveness of health PPPs in low income settings so that they can be used as a way of 
accessing private sector investment „for better delivery of health services to the poor, women 
and girls‟.44  
 
Table 8: HANSHEP projects with specific DFID involvement 
 
Project Countries Time period Funding  
African Health Markets 
for Equity  
Nigeria, 
Kenya, 
Ghana 
2012-2017 DFID/ Bill & Melinda Gates 
Foundation (BMGF)  
Health Enterprise Fund Ethiopia, 
Kenya, 
Nigeria 
2013 DFID/Rockefeller Foundation/ 
USAID 
Mining health initiative Africa/Asia 2011-2013 DFID/IFC/Rockefeller 
Foundation 
Center for Market 
Health Innovations 
Africa/Asia 2012-2016 DFID/ BMGF 
Increasing Care 
seeking behaviour for 
Childhood illnesses 
(ICARE) 
Nigeria 2014-2016 DFID/ Bill & Melinda Gates 
Foundation 
Pilot for PPP Advisory  
Facility  
Low income 
countries 
2012-2016 DFID/IFC 
Markets for Health  
(M4H) Training 
Developing 
countries 
2013-2016 DFID/ World Bank 
Source: HANSHEP www.hanshep.org 
 
DFID expenditure for HANSHEP between 2011 -2018 will be £34.7 million.  Table 9 sets out 
the DFID budget for HANSHEP from 2010-2018.   
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Table 9: HANSHEP Budget 2011-2018 
 
Financial year Value 
2011-2012 £1,204,651 
2012-2013 £5,440,886 
2013-2014 £8,488,397 
2014-2015 £6,971,832 
2015-2016 £6,071,375 
2016-2017 £4,914,860 
2017-2018 £1,696,732 
 Source: Devtracker  45 
  
The projects are supported by partnerships between DFID and IFC, Bill and Melinda Gates 
foundation, USAID and the Rockefeller Foundation, showing the range of institutional 
relationships which support the privatisation of public health services.  
 
The Business Innovation Facility 
 
The Business Innovation Facility (BIF) scheme has been running from 2010-2013 and 
supports companies to develop innovative business models which then contribute to growth, 
wealth creation, poverty reduction and meeting the Millennium Development Goals.  Nigeria, 
Zambia, Malawi, India and Bangladesh are the target countries.   
 
PwC, one of the top DFID private sector implementers, coordinates this initiative by sub-
contracting to several alliance partners, e.g. Accenture Development Partners, International 
Business Leaders Forum and Imani Development. 46  Country management teams are 
based in these “local corporate entities” national companies and screen, manage, evaluate 
BIF projects.   An Advisory Board has coordination and oversight responsibilities but no legal 
accountability for outputs.  A selection committee consists of 3 senior business experts and 
a senior DFID representative and has veto over project selection.  47  This shows the 
influence of private and corporate interests in the selection process.   
 
BIF was funded with £3.1 million but this also covered the costs of PwC coordination, so the 
total funds available for distribution are less.   PwC was given a contract for managing the 
project but it is unclear what the PwC fee for project coordination is. 
 
There were three objectives in the BIF pilot phases: technical assistance, the creation of 
partnerships between investors and companies and sharing knowledge.  Research 
undertaken by Dalrajani (2013) found that applications were developed with the country 
manager of each pilot country and evaluated by the selection committee but the criteria for 
assessment were not publicly available.  48   Some examples of funded activities include 
inclusive business strategy, developing internal business case for inclusive venture, mapping 
value chains and options, convening partners, investors, and stakeholders or providing 
sector specific expertise.  The BIF does not have any criteria to assess whether a business 
can contribute to development.  There are no formal open calls for proposals. 49  One criteria 
that BIF has identified was that a project had to have operational constraints that would 
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prevent a business project from becoming main stream business opportunity, to receive 
funding.   
 
A BIF briefing note stated that the target companies are those with projects that „are 
innovative; have the potential to achieve large scheme development impact through benefits 
to poor people; are private sector-led, with clear potential for commercial viability”. 50  An 
evaluation of the work of BIF, found that the term “large scale development impact” was an 
ambiguous term which tended to influence funders to choose companies where size was 
emphasised more than quality.  BIF has funded two health projects which both show the 
blending of healthcare with small business development. 
 
One Family Health (OFH) will establish a network of clinics providing healthcare services to 
the poor in rural, slum, and peri-urban areas of Zambia.  BIF funding provides support from 
OFH personnel, access to start-up loans, training, and negotiation assistance with suppliers 
and regulators. 51 
 
“The clinics will be owned and run by local nurses and community health workers 
operating under the OFH brand. OFH operates a business format franchise that aims 
to maintain standards, scale widely, and achieve economies of scale. The clinics will 
specifically target a short list of the main diseases causing approximately 70% of 
illness and 40% of death in sub-Saharan Africa including respiratory infections, 
malaria and dysentery.”   
 
One Family Health started operations in Rwanda and is currently expanding into Zambia, 
Nigeria, Ghana.  The founder and CEO is Dr. Gunther Faber is also Vice President of Sub-
Saharan Africa for GlaxoSmithKline Consumer Nigeria plc and has worked for 30 years in 
the pharmaceutical industry. 52 
 
Another BIF project in Nigeria is the Aceso Healthcare Partners project which is developing 
medical diagnostic clinical services.  Aceso Healthcare Partners (AHP) is a healthcare 
diagnostics provider that has only recently been registered in Nigeria. The owners are a 
group of Nigerian doctors who trained and practised in the United States.  They are aiming 
to develop alternative model of medical diagnostics services, provide value to investors and 
have a social benefit to the local community. It will use a “variety of payment models‟ to 
make their services available to poor urban communities”.   It also aims to “identify access to 
different income streams” to support long term goals.  53  54   
 
DFID Impact Investment Fund 
 
In 2012, DFID created a £75m impact investment Fund which is managed by CDC. Impact 
investments are a type of investment which aim to generate measurable social and 
environmental impact alongside a financial return. 55  Investments are made into companies, 
organisations and investment funds.   The Impact Investment fund has three partners: 
 The Global Impact Investing Network (GIIN) - a non-profit organisation which aims to 
promote impact investing through activities, training and research. 
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 The CDC Group, the UK's development finance institution, manages the DFID 
Impact Fund, a Fund of Funds. It will make investments of up to £75 million over 13 
years.    
 CDC aims to provide finance to more than 100 enterprises in Sub-Saharan Africa 
and South Asia via impact investment intermediaries and drawing in additional 
private capital.  CDC will be expected to generate “reasonable financial returns” and 
achieve a strong development impact, through the creation of jobs, both directly and 
indirectly. 
 PwC acts as the Programme Coordination Unit for the Impact Programme, working 
with CDC and the GIIN. PwC coordinates the programme, manages the technical 
assistance fund and implements a monitoring and evaluation framework.  The value 
of the PwC contract for its work as programme coordinator was £2,479,814 for 2012-
15. 56 
 
The innovative element of this impact fund is the attempt to bring together social and 
environmental impact with financial return.  In January 2014 it was announced that CDC, 
had chosen Novastar Ventures to be the first beneficiary of the IIFund.  Novastar Ventures is 
a venture capital fund which finances new businesses.   It will invest up to $15 million dollars 
over 10 years, investing venture capital in East African businesses that offer low-income 
household access to affordable healthcare, energy, housing and safe water. 57 58   
 
Public Private Partnerships 
 
Public-private partnerships (PPPs) operate at global, national, regional and local levels.  
Increasingly the contributions by the public-private partnerships of the GAVI Alliance and 
Global Fund to fight AIDS, TB and Malaria have continued to grow.  NGO contributions have 
also continued to expand.  Overall, the contribution of public-private partnerships and NGOs 
has started to overtake contributions by governments in overseas development assistance 
(ODA).  59 
 
The 2013 Health Policy Position statement illustrates DFID‟s perspectives on PPPs. 
 
“Two types of PPP operate there: with NGOs/not-for-profit agencies and with the 
commercial private sector and larger corporate groups. While both types have shown 
high levels of utilisation and benefits, recent assessments highlight the need for 
active performance monitoring, sound contract management, basic cost and quality 
monitoring. To get the most out of these partnerships and to ensure the poorest 
benefit, there is need to build capacity within the public health system to design and 
manage these partnerships.”  60 
 
As well as including NGOs and not for profit agencies as well as the commercial sector, 
DFID has identified the need for more public sector capacity to design and manage the 
contracts.  This does acknowledge that there have been problems with PPPs but there is no 
recognition that it might be the way in which the private sector negotiates and the type of 
contracts that might be major problems. 
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Although the range of public-private partnerships is continuing to expand, there is growing 
evidence that PPPs do not always deliver the expected solutions to the provision of 
infrastructure.  One of the arguments in favour of PPPs emphasises the ability of PPPs to 
access funding for infrastructure and public services faster than the public sector in times of 
austerity and cuts in government funding. 61 A major reason why governments use PPPs is 
that the money borrowed does not feature in the government accounts, thus reducing 
perceived government debt.  However, PPPs do not provide access to new sources of 
capital.  Money is borrowed from the same institutions, e.g. banks, pension funds and other 
investors as the government would borrow from, so there is no obvious benefit from using 
the private sector.  In the longer term, the government will pay more for the infrastructure 
project because it pays back to the private sector partners to cost of building and then 
managing the service. 62   The costs that the government pays for the investments and 
service provision made by the private sector are funded through taxation, in the case of 
health services.   
 
A report for International Institute for Sustainable Development (IISD) (2011) 63 found that in 
a survey of PPPs around the world, the emphasis was on „value for money‟ rather than any 
consideration of social and environmental factors.  Poor communities, particularly women, 
are often not involved in project design and remain „voiceless‟ in the process of developing a 
PPP.  PPPs involve partnerships of construction, service and financial service companies 
with the public sector/government.  There are problems of transparency in PPPs because 
they do not appear on government accounts and they are more difficult to evaluate because 
of a lack of access to commercial records.64  Government officials often do not have the 
skills to negotiate good deals with private sector companies involved in financial services.  
Poorly negotiated contracts can result in increases in government indebtedness. The 
balance of costs, benefits and risks are not always clear in PPPs.65   
 
A Eurodad report on PPPs (2015) also found that PPPs were the most expensive way of 
financing health infrastructure projects with increasing costs to public expenditure.  There is 
also considerable risk involved in PPPs for public institutions.  The complexity of PPP 
contracts and the resulting high transaction costs results in only large companies bidding for 
contracts.  This limits the choice of private sector partners for governments, which limits 
competitiveness.  There is also limited evidence of increased efficiency from PPPs.  The 
long term impact of PPP payments on the public sector is beginning to be felt by completed 
PPP projects which will weaken the budgets of public health services.  There is a lack of 
transparency in PPP contracts which obscures the profits that the private sector consortium 
are making.  This limits public accountability of projects,  66 
 
PPPs are being promoted as part of the solution to the post-2015 agenda. 67  There is a 
network of international financial institutions (IFIs), governments and corporate bodies which 
promote PPPs through marketing and campaigning globally.  The IFIs include the IMF, the 
World Bank Group, and regional development banks.  IFIs use their public funds to subsidise 
PPPs.  PPPs are also promoted in inter-governmental bodies and global corporate events.  
National development agencies also promote PPPs through funding and advice, for example 
DFID.  International legal, accounting and consultancy companies, such as PwC, are 
commissioned by national governments to publish advice and are then commissioned to 
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provide consultancy advice for government to implement PPPs.  This process of 
international lobbying for PPPs has an impact on public debates and decision making. Public 
policy becomes focused on PPPs rather than on how to reach social and economic 
objectives and the creation of publicly funded and managed infrastructure.   
 
Many of the IFC hospital investments are PPPs.  One of the best documented hospital PPPs 
is the Queen Mamohato Memorial Hospital in Lesotho.  This was described as a „IFC 
flagship model PPP‟.  In 2006, the government of Lesotho launched a PPP to build a 
hospital to replace the Queen Elizabeth II hospital.  The new hospital cost US$153 million.  
The private sector partner, Tsepong, has an 18 year contract.  The government pays an 
annual fixed services payment for the delivery of all services and the healthcare network has 
to meet all the performance standards to qualify for payment.68 
 
Table 10:  Loans for the Queen Mamohato Memorial Hospital, Lesotho 
 
Source of loan Size of loan 
Government of Lesotho US$58 
Equity capital Tsepong US$ 474.6 
Development Bank of South Africa US$ 94.9 
Source: Oxfam (2014) 
 
The total loan is ten times the budget of the health ministry but the government has also had 
to provide a loan guarantee for Tsepong.   The Development Bank of South Africa is also 
using government money.  The payments are now US$67 million per year which is three 
times what the old hospital would have cost.  This has required a 64% increase in 
government health spending over the three years (2014-2017).  It is diverting resources 
away from the rural areas where the majority of the population live.  The project is expected 
to generate a 25% return for the PPP shareholders.  69 
 
IFC provides advice for the development of new PPPs.  Table 10 shows three examples of 
recently negotiated PPPs in three poor Indian states.  Two are examples of new-build 
hospitals and a third is the building of pathology laboratories.  Indian commercial partners 
are involved in all three PPPs.  Patna Hospital will be part of one of the largest multi-
specialty hospitals in India.   IFC advice in setting up the PPPs was funded through the 
HANSHEP project which is funded by DFID.  This shows how DFID funding is being used to 
develop PPPs which involve Indian commercial healthcare companies. 
 
Table 11:  Three examples of IFC PPPs & DFID funding   
Project Consortium Amount HANSHEP 
Jharkhand 
Pathology Services 
– 25 pathology 
laboratories 
Medallo Healthcare 
Private Limited & 
SRL Ltd 
US$2 million private 
sector and 
US$360,000 
concession for 
government 
10 year contracts 
IFC advice funded 
through HANSHEP 
project funded by 
DFID 
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Bhuhaneswar 
Health Network – 
new hospital 
KPC Group – part 
US-Indian hospital 
group 
US$35 million 
private investment 
34 year contract 
IFC advice funded 
through HANSHEP 
project funded by 
DFID 
Bihar (Patna) PPP 
Design, Build,  
Finance, Operate, 
Transfer (DBFOT) 
hospital 
 
Global Health 
Patliputra Private 
Ltd (GHPPL) a unit 
of Medanta the 
Medicity (one of 
largest multi-
specialty hospitals in 
India) 
33 year concession IFC advice funded 
through HANSHEP 
project funded by 
DFID 
Source: IFC  
 
The promotion of PPPs is also taking place through the work of Healthcare UK, an 
organisation set up in 2013, to promote UK healthcare providers to “do business overseas.  
We do this by promoting the UK healthcare sector to overseas markets and supporting 
healthcare partnerships between the UK and overseas healthcare providers.” 70  It is a joint 
initiative of the Department of Health (DH), UK Trade and Investment (UKTI) and NHS 
England. 
 
The Healthcare UK Business Plans and Annual Reports show that 16 national healthcare 
markets that are targeted.  The priority markets are mainly in Asia and the Middle East but 
the new markets show that Latin America is becoming a focus of growth.  In Peru, the 
government has just chosen a competition based PPP system which will be managed by 
ProInversion, an arms-length organisation. 71  
 
Table 12: New and Priority Markets    
 
Priority markets  Turkey, Kuwait, Libya, Brazil, Saudi Arabia, 
Oman, UAE, India, Hong Kong, China, 
Indonesia 
New markets Colombia, Mexico, Peru, Nigeria, Middle 
East & North Africa 
 
Healthcare UK has facilitated several partnerships between King‟s College Hospital and 
partners in India and Abu Dhabi.  KCH Management is a commercial, consultancy, 
marketing and business company set up by King‟s College Hospital Foundation Trust.  In 
April 2015, it signed a Memorandum of Agreement with the Indo Healthcare Private Ltd and 
the Punjab government.  KCH is a strategic clinical partner for the first Indo Institute of 
Health in New Chandigarh, India, which is funded by Elara Capital. 72 
 
The example of King‟s College Hospital Foundation NHS Trust also shows how civil servants 
and politicians are involved in this process of public-private partnerships.  The Chair of 
King‟s College Hospital Foundation NHS Trust is Lord Kerslake, 73 who was Head of the UK 
Civil Service, Permanent Secretary of the Department for Communities and Local 
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Government, and chief Executive of two local authorities before he became a cross-bench 
peer in 2015. 74  Lord Maghnad Desai is a director of Elara Capital and a Labour peer in the 
House of Lords.  He was previously an academic.  75 
 
Sir David Nicholson, former head of the NHS, provides further evidence that previous public 
sector managers are now operating with private healthcare companies.  He is head of the 
Abraaj Group Health Markets Fund Impact Committee.  76  The Abraaj Group is an 
investment company which is investing in Asia, Middle East and Africa.  An example of a 
recent successful investment was in the Acidabem hospital group, the leading private 
hospital group in Turkey. Abraaj Capital investment contributed to the expansion of the 
hospital group from six to fourteen hospitals.  In 2012, Abraaj Capital sold its shares to IHH 
(Singapore/ Malaysian healthcare holding company)/Khazanah (Malaysian government 
investment fund) in exchange for cash and shares in IHH.  IHH was then launched on the 
Singapore Stock Exchange and Abraaj Capital then sold its shares. 
 
There are several examples of politicians and civil servants who have links (own shares or 
act as advisers) to private companies which work with DFID.  Lord Glendonbrook has shares 
in Siemens AG.  Lord Freeman is Chair of the Advisory Board of PWC.  Lord Ribiero was a 
former adviser on hospital re-organisation to PWC.  Lord Harris of Haringey was a former 
senior adviser to KPMG.  Mark Britnell is now Chair and Senior Partner for Global Medical 
Practice at KPMG.  He previously worked for the NHS.  77 
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Kenya – case study 
 
Table 13: Health profile of Kenya 
 
 % GDP 
healthcare 
spending 
% GDP 
Public 
health 
expenditure 
% out of 
pocket 
spending 
(as % 
private 
spending) 
Life 
expectancy 
Infant 
mortality 
rate/1000 
live births 
Maternal 
mortality 
rate/100,000 
live births 
 
2012 
5.5 60.5 67.3 W       M 
62      59 
38 540 
2013 5.6 60.1 67.4 63      59 37 525 
2014 5.7 61.3 67.4 63       60 36 510 
Source: World Bank Indicators 
 
The amount of GDP spent on healthcare is just over 5% with over 60% from public health 
expenditure.  Infant mortality and maternal mortality rates have improved since 2012.  Out of 
pocket spending as a percentage of private healthcare spending has remained at 67% since 
2012.  66% of the population are at risk of catastrophic surgery expenditure.   Catastrophic 
expenditure is defined as direct out of pocket payments for surgical and anaesthesia care 
exceeding 10% of total income. 78 
 
Out of pocket spending as a % of private health expenditure has to be understood in relation 
to overall private sector overall spending and public health spending. In medium income 
countries, such as Kenya, where there have been decreases in public health spending but 
high levels of out of pocket spending, households will be strongly affected by these changes.   
Individual households have to pay more directly for medicines and healthcare treatments.   
 
For individuals or households who are unable to afford the costs of health insurance and are 
unable to access publicly funded healthcare, their only option may be to pay for healthcare 
when they need it.  This may involve paying a private practitioner or a public facility.  This 
has important implications for households because a decision whether to access healthcare 
will be determined by whether they have enough money to pay rather than their healthcare 
need.79   Individuals may leave treatment until a condition is more serious. It can lead to 
higher rates of catastrophic healthcare expenditure, which can devastate household income.  
Only very small increases in fees can result in a decrease in service use by poor 
households.  This reduced access to healthcare results in worsening levels of ill-health and 
higher mortality rates. 80 
 
The DFID Kenya Health Programme (£106.3m) ran between 2009 and 2015.  It was 
implemented with partners Population services International (PSI), World Health 
Organisation (WHO), the MENTOR Initiative, Family Care International (FCI) MENTOR 
Initiative, and Kings College London (KCL)‟  All organisations work closely with the Ministry 
of Health.  81  Although part of the DFID health programme is focused on malaria prevention 
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and control, HIV/AIDS and reproductive health, the strengthening of health systems forms an 
important part of the programme.    
 
DFID has been working in the same environment as the Health Policy Project, which is 
funded by USAID and PEPFAR (The US President‟s Emergency Plan for Aids Relief) and 
aims to strengthen health systems during a transition period to devolved government and 
decentralised health infrastructure and to strengthen the use of results-based health 
financing and budgeting.   Technical assistance is provided to:  
 
“formulate effective new health policies and laws. We also work with government and 
health institutions to develop effective and efficient financing mechanisms that 
maximize the country‟s funding resources to deliver high-quality, equitable, and 
affordable healthcare services to all Kenyans.” 82 
 
The Health Policy Project is in the process of changing the way in which the health system is 
financed and organised, with an emphasis on containing costs and monitoring services.  The 
World Bank and WHO are two multi-lateral agencies involved in this project. 
 
A report (2012) „The Next 33,000,000‟ by Open Capital Advisors, a company providing 
investment advice in Africa, was written for healthcare investors and shows how Kenya is 
seen as having investment and innovation opportunities in the healthcare sector.  The report 
sets out the case for the private sector role in the healthcare sector and shows how the 
healthcare is seen as a commodity which requires the development of a market.  Investors 
recognise that Kenya has a growing demand for healthcare and have invested in medical 
insurance and healthcare provision.   It argues that public healthcare expenditure is 
expected to continue to fall and as a result the private sector will have opportunities for 
expanding into provision of healthcare services.  It estimated that Kenya private healthcare 
sector will need $US1.4 billion by 2025.  This size of investment will require private equity 
investors rather than “retained earnings or debt”. 83 
 
The report argues that the challenge for the private healthcare sector is to change the focus 
of „consumers‟ to become more value-focused rather than cost sensitive.  “Entrepreneurs will 
have to price carefully in the face of competitors subsidized by aid, NGOs and government.”  
84  
The report then examines the options for private healthcare insurance - private mass market 
health insurance.  The development of private health insurance is one of the first hurdles that 
private healthcare providers have to solve because without private health insurance, patients 
can only pay „out of pocket‟ which restricts what can be sold to the patient.  The Open 
Capital Advisors report shows how Kenya is being promoted as a potential growth centre for 
private healthcare.  It complements a recent DFID funded project which shows how the 
promotion of privatisation is not just through the funding of private and corporate hospitals 
and facilities.  It is also through the development of a way of working which is being 
promoted to local healthcare workers and services users.  One of the biggest challenges for 
private healthcare in many low/ medium income countries is for people to be willing to pay 
for higher quality and therefore more expensive healthcare.   
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The DFID funded project „Private sector Innovation Programme for Health‟ (PSP4H) applied 
the Making Markets Work for the Poor (M4P) approach to healthcare.  It worked with 12 
projects to develop local healthcare markets for 2.5 years.  These were:   
 
 Health insurance for informal workers 
 Bungoma Midwives 
 Business Schools training 
 City Eye hospital 
 County engagement with PHPs 
 Jacaranda Maternal health services 
 Labnet 
 Pharmnet  
 PSK-Tunza 
 Tanaka Nursing home 
 Live Well Viva Afya 
 
The programme was evaluated by Cardno Emerging Markets, a consultancy group which 
works in a wide range of sectors. The evaluation conclusions show the underlying 
assumptions about private healthcare which have been made by the evaluators.  The 
Bungoma Midwives project was described as having a “NGO mentality and expected 
financial support in return for cooperation.”  85  The City Eye Hospital project was felt to need 
to “work on developing a sound business model (e.g. understanding breakeven, product mix, 
cross-subsidy).” 86  The Jacaranda Maternal Health Services Project was evaluated as not 
understanding Markets for Poor People (M4P) well and so opted for donor funds and failed 
to assess financial sustainability.  The overall conclusion was that the project has only been 
implemented for 2.5 years and more time was needed.  This points to a focus on how the 
projects often failed to either understand the process of business planning or chose other 
options to develop their services.  Overall, the PSP4H project was trying to introduce 
business thinking to local healthcare services.   
 
Kenya is an example of a country which received three IFC loans for new hospital and 
healthcare services.  It is the focus of attention for private healthcare investors.  DFID is 
contributing to attempts to change the balance of health services from public to private.  
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Liberia – case study 
 
Table 14: Liberia health profile 
 
 % GDP 
healthcare 
spending 
% GDP 
Public 
health 
expenditure 
% out of 
pocket 
spending 
(as % 
private 
spending) 
Life 
expectancy 
Infant 
mortality 
rate/1000 
live births 
Maternal 
mortality 
rate/100,000 
live births 
 
2012 
10.2  33.2   44.8 W     M 
61     59 
57 762 
2013 9.3 30.6 44.8 62     60 55 741 
2014 10.0 31.5 44.8 62     60 53 725 
 
Compared to Kenya, Liberia has a higher % of GDP spending on health but a lower 
percentage of this is public health expenditure.  Infant mortality and maternal mortality rates 
are higher than Kenya, although they have improved slightly since 2012.  Out of pocket 
spending as a % of private spending is lower than in Kenya but the risk of catastrophic 
health surgery expenditure is about the same at 60%.   
 
In Liberia, DFID has contributed to the Health Sector Pool Fund (HCSF) and the Liberia 
Reconstruction Trust Fund (LRTF), which are both multilateral donor funds.  It took a lead in 
the Health Sector Pool Fund (HSPF), which was established in 2008 to coordinate donor 
agencies and the Government of Liberia‟s national health policies and plans.  DFID is a 
member of the Steering Committee, alongside the World Health Organisation (WHO), the 
World Bank, the European Union and USAID, who are part of a Joint Financing Agreement 
with the Ministry of Health & Social Welfare.  All activities funded by the HSPF are based on 
proposals initiated by the Ministry of Health and Social Welfare and agreed by the Steering 
Committee.  DFID provided £12 million for the Health Sector Pool Fund between 2010 and 
2013.  87 
 
DFID spends £15 million in Liberia, 65% of its total budget, through multi-lateral agencies.  
DFID staff sit on programme boards, e.g. Liberia Reconstruction Trust. The International 
Development Committee, following a visit to Liberia, reported that there was good 
cooperation between DFID and World Bank staff because they shared a “similar world view”.  
88 NGOs based in Liberia had questioned DFID‟s use of multilateral agencies because they 
did not always provide adequate oversight of projects. 89  Other centrally managed 
programmes were often run by consultants rather than DFID staff.  Again, NGOs were 
critical of the influence of commercial consultancies which had limited experience of social 
programmes.   
 
An example of how multi-lateral agencies promote PPPs in healthcare can be seen in the 
report from the EU about a second Poverty Reduction Strategy (PRS-II) for Liberia in 2012.  
The EU reported that: 
 
 
 
 
 
 
33 
 
“The PRS-II also stresses the importance of improving efficiency and effectiveness, 
e.g. by developing viable and equitable healthcare financing options, efficient use of 
key inputs such as human resources for health and efficient models for public-private 
partnerships.” 90 
 
As part of DFID‟s aid budget goes to the EU, this shows how support for multi-lateral 
agencies is also supporting the promotion of PPPs. 
 
Although DFID support had been essential to the improvement of Liberia health services, the 
International Development Committee “were shocked to find that $3.9 million of $60 million 
EU health sector support had been passed on from the Ministry of Finance to the Ministry of 
Health over a two year period, leaving the Liberian health system struggling.” 91 DFID and 
the EU had not been active in resolving this situation.   Although this problem has now been 
addressed, this illustrates the power of finance ministries over health ministries, an 
underlying feature of health sector reform. 
 
One of the major problems facing the Liberia health system after Ebola crisis is the shortage 
of trained nurses and doctors.  The International Development Committee (IDC) commented 
on this and were concerned that about 10% of trained nurses were working in the UK.  It 
recommended that DFID should make contacts with UK healthcare institutions and 
professionals and those working in Liberia and Sierra Leone. 92 
 
The future of DFID funding of the Liberia health sector was also raised by the IDC and 
illustrates the potential impact of changes in DFID‟s priorities which are moving from direct 
bi-lateral aid to working with multi-lateral agencies on wider issues of poverty reduction.  
DFID funding of the Liberia health sector was due to end in 2014.  Although funding has 
continued as a result of the Ebola crisis, health funding is not expected to continue long-
term. The initial reaction of the Liberia Health Ministry to the proposed cut in funding was to 
recommend that user fees would have to be re-introduced.  DFID‟s funding of the health 
sector since 2008 has enabled Liberia to abolish user fees for health services.  
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Nepal – case study  
 
Table 15: Nepal health profile 
 
 % GDP 
healthcare 
spending 
% GDP 
Public 
health 
expenditure 
% out of 
pocket 
spending 
(as % 
private 
spending) 
Life 
expectancy 
Infant 
mortality 
rate/1000 
live births 
Maternal 
mortality 
rate/100,000 
live births 
 
2012 
5.9 41.9  79.0 W       M 
70      67 
32 291 
2013 5.7 39.0 79.9 71       68 31 275 
2014 5.8 40.3 79.9 71       68 29 258 
 
In Nepal, the percentage of GDP spent on healthcare is over 5%, similar to Kenya but the 
percentage of public health expenditure is lower than Kenya.  Out of pocket spending as a % 
of private spending is higher than either Kenya and Liberia and the risk of catastrophic 
health surgery expenditure is also higher at 75%. 
 
DFID has been involved in funding a Nepal Health Sector Support Programme which aims to 
address ways of financing health services as well as developing a health financing strategy 
with other sector partners. 93   
 
DFID was involved in a PPP for TB control in Lalitpur municipality, Nepal, where 50% of 
patients were managed by private practitioners.  This is an example of a PPP which worked 
with private practitioners, rather than using private capital.   There are over 14,000 new 
cases of TB notified each year in Nepal.  Over 50% of cases in urban areas are treated by 
private practitioners.  The Laltpur District Public Health Office (DPHO) was responsible for 
managing the PPP scheme. This included providing training for laboratory staff and Directly 
Observed Treatment (DOT) supervisors, supervising workers involved in TB control, 
ensuring supply and distribution of medicines, and ensuring that five Treatment Centres 
(TCs) followed standard NTP recording and reporting guidelines.  A semi-governmental 
hospital (Patan Hospital), three NGOs (Yala Urban Health Programme (YUHP), Nepal Anti-
TB Association (NATA) and a private nursing home which ran private outpatient clinics in the 
mornings and evenings) were invited to become treatment centres for Directly Observed 
Treatment.  No financial incentives were paid to the participating organisations.   
 
An evaluation found that if the scheme was to be scaled up there were several issues which 
would have to be addressed: the low staff costs as compared to other health systems; the 
use of unpaid volunteers which might have replaced by paid staff in other systems and; the 
high social costs to patients. Although patients were given free treatments, they had to pay 
for travel to clinic and for diagnosis costs.  The cost of accompanying women patients was 
higher than for male patients. Overall costs for women patients were higher than for men 
because women required more chaperoning.   Costs by men who self-referred or were 
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referred from semi-government facilities were also higher than for women although the 
numbers in the sample were small.  The study found that the costs for families of patients 
were significant and could limit patients from accessing treatment. 94    This example of a 
PPP is a contrast to larger PPP infrastructure projects and it shows that the process of 
collaborating between the public and private sector can be focused on a specific treatment.   
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Conclusion 
 
This report has shown that DFID‟s expenditure through CDC and multilateral agencies, such 
as the World Bank Group, is contributing to the implementation of policies which are 
promoting the privatisation of health services and encouraging healthcare to be considered a 
commodity to be bought rather than a public service which is free at the point of use.  This is 
a fundamental change for many countries and will benefit investors in healthcare rather than 
patients.  The hospital investments of the IFC will benefit higher income groups.  The smaller 
partnership investments which DFID contributes to will support the development of smaller 
private healthcare providers.   
 
DFID expenditure is contributing to the expansion of PPPs.  This results from DFID support 
for multi-lateral agencies, such as the International Finance Corporation (IFC), which invest 
directly in PPPs.  DFID has also set up initiatives which encourage and facilitate the 
development of PPPs, for example, HANSHEP.  In this sense, DFID is not only directly 
promoting PPPs but is also creating policy environments which will promote PPPs in future. 
 
All three country case studies showed that out-of-pocket spending was already high and the 
risk of catastrophic surgical spending was much higher.  The majority of the populations 
lacks access to safe, reliable and free health services.  The promotion of privatisation at 
whatever level will not increase accessibility but will channel resources to a private sector.  
Recent DFID policies do not recognise the role of the public sector except as a last resort for 
very poor people.  This means that the concept of universalism, where risks are shared 
across the whole population, is being abandoned.  There is evidence to show that public 
health services reduce mortality and contribute to economic growth.  Public health services 
should be recognised as the foundation of all aid and development policies. 
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